Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Radiotherapy After Primary CHEMotherapy for cT1-2cN1M0 Breast Cancer.: a Multicentre Prospective Registration Study.

NCT01279304 is registered in ClinicalTrials.gov with Maastricht Radiation Oncology as lead sponsor.

NCT NCT01279304
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01279304 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Radiotherapy After Primary CHEMotherapy for cT1-2cN1M0 Breast Cancer.: a Multicentre Prospective Registration Study.
Lead sponsor
Maastricht Radiation Oncology
Phase
Observational
Overall status
Completed
Start date
January 31, 2011
Completion date
December 31, 2017
Enrollment
851 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer